Colab Platforms Limited has received board approval to list its equity shares on the Metropolitan Stock Exchange of India Limited (MSEI), marking a significant step in expanding its stock exchange presence. The decision was unanimously approved during a board meeting held on January 22, 2026.

Board Meeting Details

The board meeting was conducted at the company's registered office and chaired by Managing Director Puneet Singh Chandhok. The meeting proceedings were efficiently managed within a 30-minute timeframe.

Key Resolution Approved

The primary agenda item addressed during the meeting focused on expanding the company's stock exchange listing footprint. The board formally approved the listing of Colab Platforms Limited's equity shares on MSEI, demonstrating the company's commitment to enhancing market accessibility for investors.

The approval comes with standard regulatory conditions that must be fulfilled before the listing becomes effective. These include obtaining necessary approvals from relevant authorities, securing required consents, and ensuring compliance with all applicable regulations and requirements.

Regulatory Compliance

The announcement was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.

Colab Platforms Limited is currently listed on BSE Limited under the script code 542866 and script ID COLAB. The addition of MSEI listing would provide investors with an additional platform for trading the company's shares, potentially improving liquidity and market reach.

Next Steps

The company will now proceed with the necessary regulatory processes to complete the MSEI listing. This includes submitting applications to relevant authorities, fulfilling documentation requirements, and ensuring compliance with MSEI's listing norms and procedures. The timeline for completing the listing process will depend on regulatory approvals and the fulfillment of all prescribed conditions.

Colab Platforms Limited has announced the grant of 813 stock options to eligible employees under its Employee Stock Option Plan 2024, marking a significant step in the company's employee retention and incentive strategy. The Nomination and Remuneration Committee of the Board of Directors approved this grant on January 7, 2026, in compliance with regulatory requirements.

ESOP Grant Details

The stock options were granted under the Colab Cloud Employee Stock Option Plan 2024, following the guidelines established by SEBI regulations. The grant encompasses specific parameters designed to align employee interests with company performance.

Regulatory Compliance

The grant adheres to Regulation 30 and Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, it complies with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Vesting and Exercise Terms

The stock options come with structured vesting and exercise provisions designed to ensure long-term employee commitment. The vesting schedule will be specified in individual grant letters issued to eligible employees.

Current Status

As of the grant date, no options have been vested or exercised, which is expected given the recent approval. The options will vest according to the schedule outlined in individual grant letters, with employees having the opportunity to exercise their options within one year of vesting.

The announcement was made through a formal communication to BSE Limited, with Managing Director Puneet Singh Chandhok signing the disclosure document. This ESOP grant represents Colab Platforms Limited's commitment to employee participation in the company's growth and success through equity-based compensation.